View of A Comparative Study of The Effectiveness of Pfizer-BioNTech (BNT162b2), AstraZeneca (ChAdOx1nCoV-19) and Sinopharm (BBIBP-CorV) Vaccines in Eliciting Cell Mediated and Humoral Immunity in A Sample of Vaccinated Population from Iraq

Return to Article Details A Comparative Study of The Effectiveness of Pfizer-BioNTech (BNT162b2), AstraZeneca (ChAdOx1nCoV-19) and Sinopharm (BBIBP-CorV) Vaccines in Eliciting Cell Mediated and Humoral Immunity in A Sample of Vaccinated Population from Iraq Download Download PDF